ELEVATING PV QUALITY AND COMPLIANCE VIA COMMUNITY COLLABORATION AND DIGITAL HEALTH APPLICATIONS
With major product recalls in recent years – including the suspension of 700 products earlier this year due to fake clinical trials, regulatory authorities across Asia are tightening regulations to safeguard consumer health. Hence, it is vital that pharmacovigilance professionals process these safety reports in an accurate and timely manner, while negotiating the diverse and often ambiguous regulatory requirements across the region.
7th Annual Pharmacovigilance Asia 2016 takes a look at creating a more pro-active and quality-assured pharmacovigilance system in Asia, as well as building sustainability and capability in Asia.
Join our regional and global thought leaders from top firms as they share real-life examples, case studies and best practice on how to re-evaluate and optimize their processes and people throughout the product’s life cycle.